CCR8 as a novel biomarker for the specific targeting of a highly suppressive tumor infiltrating regulatory T cell subset.

This abstract has been prevented from online publishing. Please contact the author(s) during the conference for more information. 

Authors

"Helena Van Damme1,2,*, Eva Van Overmeire1,2,*, Evangelia Bolli1,2, Mate Kiss1,2, Aleksandar Murgaski1,2, Andrea Casazza3,4, Maria Solange Martins1,2, Yvon Elkrim1,2, Frank Tacke5, Massimiliano Mazzone3,4, Sofie Struyf6, Kiavash Movahedi, Isabelle Scheyltjens Damya Laoui1,2, ‡ and Jo A. Van Ginderachter1,2, ‡ "

Organisations

"1 Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium 2 Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium 3 Lab of Tumor Inflammation and Angiogenesis, VIB, Leuven, Belgium 4 Lab of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium 5 Department of Medicine III, RWTH University-Hospital Aachen, Aachen, Germany 6 Laboratory of Molecular Immunology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium • Equal contribution, ‡ Shared senior authorship "

Presenting author

Helena Van Damme, PhD Student, VIB-VUB
Helena.Van.Damme@vub.be
Contact us now

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners